Development of a novel ultrashort antimicrobial peptide-levofloxacin conjugate with enhanced synergistic activity against multidrug and levofloxacin-resistant bacterial isolates

Background and purpose: Antimicrobial resistance poses a significant global health threat. A previously developed penta-amino acid ultrashort antimicrobial peptide (UP5), with alternating arginine and biphenylalanine units, showed strong antimicrobial activity, particularly in combination with levof...

Повний опис

Бібліографічні деталі

Автори:	Ammar Almaaytah, Aseel Alrashdan, Salsabeel H Sabi
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Wolters Kluwer Medknow Publications 2025-11-01
Серія:	Research in Pharmaceutical Sciences
Предмети:	antimicrobial peptide antimicrobial resistance conjugation drug design levofloxacin synergism
Онлайн доступ:	https://journals.lww.com/10.4103/RPS.RPS_178_24
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!